Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis

Pathology International

Volumn 58, Issue 3, 2008, Pages 203-207

  Kobayashi, Makoto ^a   Takeuchi, Tamotsu ^b   Ohtsuki, Yuji ^c  

^a Hosogi Unity Hospital   (Japan)

^b KOCHI UNIVERSITY   (Japan)

^c Matsuyama Shimin Hospital   (Japan)

Author keywords

Anti GM CSF antibody; Immunohistochemistry; Intra alveolar substance; Surfactant proteins

Indexed keywords

EOSIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; HEMATOXYLIN; MONOCLONAL ANTIBODY; PROTEIN KL 6; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CA-15-3 ANTIGEN; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; MALE; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANTS; RADIOGRAPHY, THORACIC;

EID: 38849185964     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02212.x     Document Type: Article

References (20)

1. Rosen SG, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958 258:1123 42.
2. Seymour JF, Presnell JJ. Pulmonary alveolar proteinosis: Progress in the first 44 years. Am J Respir Crit Care Med 2002 166:215 35.
3. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003 349:2527 39.
4. Uchida K, Nakata K, Trapnell BC et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2004 103:1089 96.
5. Kitamura T, Tanaka N, Watanabe J et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte-macrophage colony-stimulating factor. J Exp Med 1999 190:875 80.
6. Kohno N, Awaya Y, Oyama T et al. KL-6, a mucin-like glycoprotein in bronchoalveolar lavage fluid from patients with interstitial lung diseases. Am Rev Respir Dis 1993 148:637 42.
7. Tazawa R, Nakata K, Inoue Y, Nukiwa T. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: A pilot study; and long term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: A case report. Respirol 2006 11:S61 4.
8. Inoue T, Matsuura E, Nagata A et al. Enzyme-linked immunosorbent assay for human pulmonary surfactant D. J Immunol Methods 1994 173:157 64.
9. Takeuchi T, Misaki A, Fujita J, Sonobe H, Ohtsuki Y. T-cadherin (CDH13, H-cadherin) expression downregulated surfactant protein D in bronchoalveolar cells. Virchows Arch 2001 438:370 75.
10. Kobayashi M, Takeuchi T, Adachi Y, Uemura Y, Ohtsuki Y, Taguchi H. Establishment of three novel human malignant pleural mesothelioma cell lines. Morphological and cytogenetical studies with EGFR mutation status. Anticancer Res (In press).
11. Honda Y, Takahashi H, Shijubo N, Kuroki Y, Akino T. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest 1993 103:496 9.
12. Crouch E, Persson A, Chang D. Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am J Pathol 1993 142:241 8.
13. Whitsett JA, Horowitz AD. Surfactant and associated proteins. In:Fishman AP, Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM, eds. Fishmaǹs Pulmonary Diseases and Disorders, 3rd edn. New York:McGraw-Hill, 1998 119 27.
14. Kishore U, Greenhough TJ, Waters P et al. Surfactant proteins SP-A and SP-D: Structure, function, and receptors. Mol Immunol 2006 43:1293 315.
15. Takahashi T, Munakata M, Suzuki I, Kawakami Y. Serum and bronchoalveolar lavage fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 1998 158:1294 8.
16. Seymour JF, Doyle IR, Nakata K et al. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis. Thorax 2003 58:252 7.
17. Wang BM, Stern EJ, Schmidt RA, Pierson DJ. Diagnosing pulmonary alveolar proteinosis. Chest 1997 111:460 66.
18. Dail DH. Metabolic and other diseases: Pulmonary alveolar proteinosis. In:Dail DH, Hammar SP, eds. Pulmonary Pathology. New York:Springer, 1987 561 7.
19. Brasch F, Birzele J, Ochs M et al. Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur Respir J 2004 24:426 35.
20. Crouch E, Persson A, Parghi D. Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis. Am J Pathol 1991 139:765 76.